TARA
Protara Therapeutics Inc.
Company Overview
| Mkt Cap | $196.38M | Price | $5.18 |
| Volume | 300.27K | Change | +0.78% |
| P/E Ratio | -4.4 | Open | $5.11 |
| Revenue | -- | Prev Close | $5.14 |
| Net Income | $-44.6M | 52W Range | $2.21 - $10.48 |
| Div Yield | N/A | Target | $25.00 |
| Overall | 53 | Value | 60 |
| Quality | 36 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyProtara Therapeutics Inc. (TARA) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $5.18 with a market capitalization of $196.38 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows TARA with a volume of 300K shares. The stock opened down 0.58% from yesterday's close of $5.14. Current analyst estimates project earnings of $-1.45 per share for this year, with next year targeting $-1.76.
TARA demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TARA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 382.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:04 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARA | $5.18 | +0.8% | 300.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW